ALZI.V Alzai Health Corp.
- Market cap
- CAD 10.4M
- P/E
- -
- P/B
- 7.23x
- ROE
- -261.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is ALZI.V undervalued?
Graham numberThe Graham number of Alzai Health Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alzai Health Corp. fundamental analysis
No fundamental analysis for Alzai Health Corp. yet.
Alzai Health Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Alzai Health Corp.
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2…
Full company profileAlzai Health Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Alzai Health Corp. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2026 | 2026 Anlz |
|---|---|---|
| Income Statement | ||
| Revenue | 27.0K | 168K |
| Operating Income | -3.62M | -3.73M |
| EBITDA | -3.60M | -3.81M |
| Net Income | -3.68M | -3.99M |
| EPS | -0.07 | -0.06 |
| Balance Sheet | ||
| Total Assets | 526K | 2.57M |
| Total Liabilities | 1.85M | 1.05M |
| Shareholders' Equity | -1.32M | 1.52M |
| Cash & Short-term Investments | 268K | 1.91M |
| Cash Flow | ||
| Operating Cash Flow | -2.59M | -6.47M |
| Capital Expenditure | 19.4K | 0.00 |
| Free Cash Flow | -2.61M | -6.47M |
| Ratios | ||
| ROE | - | -261.6% |
| ROA | -698.6% | -155.0% |
| Net Profit Margin | -13,593.1% | -2,369.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Alzai Health Corp. dividends
Alzai Health Corp. has not paid dividends in the last 1 fiscal years.
Who owns Alzai Health Corp.
- Insiders 13.73%
- Institutions 0.00%
- Public & others 86.27%
- Shares outstanding 64.8M
- Free float 55.9M
Alzai Health Corp. company profile
- Company name
- Alzai Health Corp.
- Ticker
- ALZI.V
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 5
- Fiscal year end
- April
- Address
- 22 Adelaide Street West, Toronto, ON, Canada, M5H 4E3
- Phone
- 416 862 4351
- Website
- alzaihealth.com
About Alzai Health Corp.
Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer's Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2024 and is based in Toronto, Canada.
Alzai Health Corp. management
8- Mr. Hayim RaclawCo-Founder, Chairman & CEO · born 1976
- Mr. Roy KaitCo-Founder, Chief Revenue Officer & Director · born 1977
- Dr. Amir Glik M.D.Co-Founder, Chief Medical Officer & Director · born 1977
- Dr. Chen HajajCo-Founder & Head of Data Science
- Dr. Anat GoldsteinCo-Founder & AI Expert
- Mr. Ofri KaitCo-Founder, Director of Business Development & Operations
- Mr. Israel MesserCFO & Corporate Secretary · born 1975
- Jenny GreerDirector of Administration